Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue [Yahoo! Finance]
Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue
Twist Bioscience (TWST) Valuation Check After TD Cowen Buy Rating And Raised Outlook [Yahoo! Finance]
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Cowen Inc.